Zydus Cadila Healthcare Limited Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Zydus Cadila Healthcare Limited's estimated annual revenue is currently $3.5M per year.(i)
  • Zydus Cadila Healthcare Limited's estimated revenue per employee is $2,313

Employee Data

  • Zydus Cadila Healthcare Limited has 1513 Employees.(i)
  • Zydus Cadila Healthcare Limited grew their employee count by -3% last year.

Zydus Cadila Healthcare Limited's People

NameTitleEmail/Phone
1
PA to The PresidentReveal Email/Phone
2
IT OfficerReveal Email/Phone
3
SVPReveal Email/Phone
4
Executive OfficerReveal Email/Phone
5
OfficerReveal Email/Phone
6
Trainee officerReveal Email/Phone
7
Security OfficerReveal Email/Phone
8
SVP - Head Demand FulfillmentReveal Email/Phone
9
OfficerReveal Email/Phone
10
Security OfficerReveal Email/Phone

What Is Zydus Cadila Healthcare Limited?

Zydus Cadila Healthcare Limited is a biotechnology company based out of Zydus Tower Opp Fun Republic Satellite Cross Roads Satellite Road, Ahmedabad, Gujarat, India.

keywords:N/A

N/A

Total Funding

1513

Number of Employees

$3.5M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zydus Cadila Healthcare Limited News

2022-04-20 - Tofacitinib Market By Strength, Drug Class, Dosage Form ...

... Limited, Pfizer Inc., Globe Pharmaceuticals, Delta Pharma Limited, ... Octagon Chemicals Limited, APINO PHARMA CO., LTD., Zydus Cadila,...

2022-04-17 - H3N2 Infection Treatment Market Foresight By 2031 ...

... OPKO Health Inc., Sarepta Therapeutics Inc., Takeda Pharmaceutical Company Limited, Visterra Inc., Zydus Cadila Healthcare Limited.

2022-04-17 - Hydroxychloroquine And Chloroquine Market Size, Scope ...

... Ipca Laboratories, Zydus Cadila, Sanofi S.A., McW Healthcare, Macleods Pharmaceuticals Ltd, Cipla Limited, Lupin Limited, Mylan N.V., Abbott India Ltd.

2021-11-18 - Cadila Healthcare : Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA

www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete. Reference ID IP Address Date and Time 7b6c401d4a92eeb62dcf1d26bc03e483 3.138.189.47 11/18/2021 05:12 AM UTC Attachments ...

2021-11-10 - Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection

Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection Ahmedabad, India, 10 November, 2021 Zydus Cadila has received final approval from the USFDA to market Glycopyrrolate Injection in the strengths of 0.2 mg/mL and 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Vials and 1 mg/5 mL ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$309.8M15265%N/A
#2
$167.9M16717%N/A
#3
$343.3M16919%N/A
#4
$312.3M17169%N/A
#5
$391.4M192811%N/A